Press "Enter" to skip to content

FDA Approves ‘First-of-Its-Kind’ Alzheimer’s Treatment

The Food and Drug Administration (FDA) on Monday approved what it described as a “first-of-its-kind” treatment for Alzheimer’s disease, which it says “targets the fundamental pathophysiology of the disease.”

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *